Book a Meeting

Anti-ICOS Antibody, Non-Fucosylated (BioBet-1022ZP) (CAT#: BioBet-1022ZP) Datasheet

Target
ICOS
Isotype
IgG
Description
ADCC-Enhanced anti-ICOS (53-3) is a non-fucosylated therapeutic biobetter antibody engineered by Creative Biolabs' Afuco™ technology platform.
Antibody Indication
Autoimmune Diseases
Classification
Therapeutic antibody; biobetter

Cooperation Seeking

Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced ICOS antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Official Name
ICOS
Full Name
inducible T-cell co-stimulator
Background
The protein encoded by this gene belongs to the CD28 and CTLA-4 cell-surface receptor family. It forms homodimers and plays an important role in cell-cell signaling, immune responses, and regulation of cell proliferation.
Alternative Names
ICOS; inducible T-cell co-stimulator; AILIM; CD278; CVID1; inducible T-cell costimulator; inducible costimulator; activation-inducible lymphocyte immunomediatory molecule
Gene ID
UniProt ID
Cellular Localization
Plasma membrane, Extracellular region or secreted
Involvement in Disease
Diseases associated with ICOS include Immunodeficiency, Common Variable, 1 and Common Variable Immunodeficiency.
Related Pathways
Its related pathways are RET signaling and Signaling by GPCR.
Function
It enhances all the basic responses of t cells to foreign antigens, namely proliferation, secretion of lymphokines, up-regulation of intercellular interaction molecules, and effectively helps b cells to secrete antibodies. It is essential for the effective interaction between T cells and b cells and the normal antibody response to T cell dependent antigens. Does not up-regulate the production of interleukin-2, but super induces the synthesis of interleukin-10. Prevent the apoptosis of pre-activated t cells. It plays a key role in cd40-mediated isotype switching (through similarity) of immunoglobulins.
Post-translational modifications
N-glycosylated.
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Antibody Isotype
IgG
Antibody Clone
53-3
Host
Chimeric
Species Reactivity
Human
Description
The antibody directed against ICOS can induce IL-10 and IFNγ production, induce CD4+ T cells proliferation, reduce Tconv proliferation, and increase the immunosuppressive function of Treg.
Antibody Indication
Autoimmune Diseases

Autoimmune Diseases

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK

Germany

ISO 9001 Certified - Creative Biolabs Quality Management System.